Stop Guessing.
Start Knowing.
Intelligence Straight from the Decision-Makers Who Control Access
What do payers think about your brand? How will a P&T committee evaluate your drug before it’s even reviewed? What’s blocking utilization at a specific health system? These aren’t rhetorical questions. They’re the ones MMIT’s Market Research and Insights solutions are built to answer. Powered by Norstella’s industry-leading panel of 500+ active payer, IDN, and HCP decision-makers, MMIT gives your team the intelligence to stop guessing and start acting.
Why MMIT's Insights Are Different
Every insight MMIT delivers traces back to direct access to the people making the decisions. Norstella’s industry-leading panel spans payers, IDNs, and HCPs, all actively participating in the formulary and coverage decisions that shape your brand’s access.
Built for the Questions Coverage Data Can't Answer
Smart Access
Most teams find out how payers will cover their drug after launch. Smart Access changes that, using AI-powered analog modeling and 10+ years of MMIT payer intelligence to forecast coverage, restrictions, and payer speed before day one.
See the Forecast
Message Monitor
Your team leaves every payer meeting without knowing how it landed. Message Monitor closes that gap, delivering structured payer feedback within 48 hours scored by active P&T committee members on Relevancy, Credibility, and Delivery.
See How It Works
P&T Perspectives
Know how your drug will be evaluated before it enters the room. P&T Perspectives puts your product in front of a simulated P&T committee, giving you a clear view of likely restrictions, competitive positioning, and formulary placement outcomes.
Explore P&T Perspectives
IDN Formulary Insights
Formulary placement does not guarantee utilization. IDN Formulary Insights gives your account teams deep visibility into how individual health systems are managing your therapeutic area at the account level.
Get Inside the Health System
Custom Market Research
Your most critical access questions deserve purpose-built answers. MMIT pairs its industry-leading panel with market access experts to deliver research tailored to your specific challenge, from launch pricing to loss of exclusivity planning.
Build Your Research
Engage
When you need payer perspective fast, Engage connects you with active decision-makers in 48 hours. Ask targeted questions and watch payers respond in real time through a moderated discussion board.
Get Answers Fast
Rapid Response
Get quantitative payer intelligence with expert analysis in days, not months. Rapid Response delivers survey-based insights from 10 to 20 targeted payer and IDN decision-makers, complete with an expert-led executive summary.
Start Your Research
Oncology Index
Payer management in oncology moves fast. The Oncology Index delivers quarterly insights into coverage decisions, restriction trends, and payer-IDN dynamics across targeted oncology therapeutic areas, so your national and regional strategy is always built on current intelligence, not last quarter’s assumptions.
STAY AHEAD OF TRENDS
Biologics & Injectables Index
Understanding how payers manage biologics requires more than coverage data, it requires unblinded perspectives from the people making the decisions. The Biologics & Injectables Index surfaces quarterly payer reactions to coverage, site-of-care shifts, and emerging therapies, backed by a panel representing 75% of Commercial and Medicare lives.
ACCESS THE INDEX
What the Data Reveals
Improving Access with Market Research Insights
A guide to the market research questions that matter most across the product lifecycle and how leading teams are using payer data to answer them.
What Payers Really Want: Clear, Comparable, Credible Data
Payers representing 88% of commercial lives say they want more cost-effectiveness data from manufacturers. MMIT’s Q1 2026 research reveals exactly where most teams are falling short.
What Do Payers Really Think About Your Brand?
Most teams find out their messaging missed months later when unfavorable coverage decisions come in. This piece breaks down how structured payer feedback changes that.
Reducing Risk: 5 Steps for a Fearless Launch
Drug launches fail in predictable ways. This on-demand webinar walks through five of the biggest risks and the steps teams can take to get ahead of them.
How IDN Formulary Insights Drove a 17% Utilization Gain
One oncology manufacturer used IDN-level account data to move from non-formulary to formulary at three health systems, all within six months.
Closing the Feedback Loop
Most teams never find out how their payer meeting landed. See how Message Monitor turns live meeting data into competitive intelligence in 48 hours.
Winning Payer Support for Rapid NGS Biomarker Testing in Oncology
New MMIT Rapid Response data reveals what payers require to expand liquid NGS coverage and how manufacturers can help reduce patient access delays.
The New Economics of Gene Therapy
Rising gene therapy costs are reshaping payer reimbursement, access strategies, and payment models as manufacturers prepare for the next wave of launches.
Predict Payer Access
Smart Access uses AI-ranked comparators and payer history to create more accurate, defensible coverage forecasts for launch planning.
View Payer Responses in Real Time with MMIT Engage
Engage helped a pharma manufacturer gather feedback from five P&T decision-makers in just four days to inform a critical FDA indication decision.
Talk to an MMIT Expert
Get the why behind every payer decision that affects your brand.